Vasodilators Flashcards
Nitroprusside Class
Nitrate
Direct peripheral arterial vasodilator
Non-selective relaxation of arterial & venous smooth muscle
Nitroprusside MOA
As NTP is metabolized, it releases nitric oxide and cyanide. NO activates guanylyl cyclase which synthesizes (cGMP), decreases intracellular calcium, which causes smooth muscle dilation
Nitroprusside Use
Reliable antihypertensive
Afterload reducing agent
Nitroprusside Dosing
Infusion: 0.3–10 mcg/kg/min
Nitroprusside Onset and DOA
Onset: 1 minute
DOA: 3 – 5 minutes
Nitroprusside Metabolism
Metabolized in RBC’s to cyanide which is released, then metabolized in the liver and kidneys to thiocyanate (inactive)
Nitroprusside Excretion
Thiocyanate (inactive) is slowly excreted by the kidneys
Nitroprusside Admin Considerations (8)
Caution in patients with aortic stenosis, hypertrophic cardiomyopathy, increased ICP, hypotension, heart failure
May cause headache, tachycardia and bronchodilation
Patients with renal failure may experience a build-up of thiocyantate, which may lead to thyroid dysfunction, muscle weakness, nausea, hypoxia, and an acute toxic psychosis
Dilation of coronary arterioles may result in an intracoronary steal
Reductions in pulmonary artery pressure and the hypoxic pulmonary vasoconstriction mechanism may decrease lung perfusion
Large doses of NTP may lead to methemoglobinemia and is treated with methylene blue to reduce methemoglobinemia to hemoglobin
NTP must be protected from light because of photodegradation
Patient’s on NTP infusions benefit from arterial line monitoring
Nitroglycerin Class
Nitrate
Peripheral vasodilator with venous dilation predominating over arterial dilation
Nitroglycerin MOA
As NTG is metabolized, it releases nitric oxide and cyanide. NO activates guanylyl cyclase which synthesizes (cGMP), decreases intracellular calcium, which causes smooth muscle dilation
Nitroglycerin Uses
Relieves
- Myocardial ischemia
- Coronary vasospasm
- Hypertension
- Ventricular failure
Used for controlled hypotension
Nitroglycerin Dosing
IV Infusion: 5 – 200 mcg/min
SL: 0.4 mg
Nitroglycerin Onset and DOA
Onset: 2 minutes
DOA: 5 minutes
Nitroglycerin Metabolism
Nitroglycerin undergoes rapid reductive hydrolysis in the liver and blood by glutathione-organic nitrate reductase. One metabolic product is nitrite, which can convert hemoglobin to methemoglobin
Also have non-hepatic metabolism via RBCs and Vascular endothelial walls
Nitroglycerin Excretion
Kidneys
Nitroglycerin Admin Considerations
Headache, tachycardia can occur
Tolerance may develop with prolonged use
Caution in patients with aortic stenosis, hypertrophic cardiomyopathy, increased ICP, hypotension, heart failure
Ideal agent for MIs
- Decrease preload will reduce myocardial oxygen demand and increases endocardial perfusion
- Redistributes coronary blood flow to ischemic areas of the subendocardium
- Relieves coronary vasospasm
Hydralazine Class
Direct acting arterial vasodilator
Hydralazine MOA
Activate guanylate cyclase to increase cGMP, decreases intracellular Ca and causes vasodilation
Hydralazine Use
Antihypertensive
This is the drug of choice with a normal or low HR
Hydralazine Dosing
Intermittent boluses: 2.5 – 20 mg
Hydralazine Onset and DOA
Onset: 15 minutes
DOA: 2 – 4 hours
Hydralazine Metabolism
Liver
Hydralazine Excreted
Kidneys
Hydralazine Considerations
Can result in reflexive tachycardia, bad for CAD
Caution in patients with aortic stenosis, hypertrophic cardiomyopathy, increased ICP, hypotension, heart failure
Can have hypersentivity reactions
Can increase Na retention with resulting hypervolemia
Nicardipine Class
Calcium channel blocker
Nicardipine MOA
Depress electrical impulses in the sinoatrial (SA) and atrioventricular (AV) nodes by blocking the influx of Ca, resulting in negative chronotropic and inotropic effects and increasing coronary and systemic vasodilation
Decreases HR, contractility, conduction velocity and vascular smooth muscle relaxation
Nicardipine Use (7)
Treatment
- Angina
- Hypertension
- Arrhythmias
- Peripheral vascular disease
- Esophageal spasm
- Cerebral vasospasm
- Controlled hypotension
Nicardipine Dosing
5 mg/hr, increased by 2.5 mg/h every 15 min up to 15 mg/hr
Nicardipine Onset and DOA
Onset: 1 min
DOA: 3 hr
Nicardipine Metabolism
Liver
Nicardipine Excretion
Kidneys
Nicardipine Admin Considerations
May cause reflexive tachycardia, bad for CAD
Caution in patients with an acute MI, heart failure, bradycardia, hypotension and on dantrolene (can increase K+ and cause myocardial depression)